Healthcare entity
regulation is the sole category represented across all 1 tracked stories. Amgen is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each story carries 4 original sources on average, compared with 2.2 for the broader beat in this window.
Last mentioned: Jul 27, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
regulation is the sole category represented across all 1 tracked stories. Amgen is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each story carries 4 original sources on average, compared with 2.2 for the broader beat in this window. At 5, the average consequence score sits below the same-window beat average of 6. We currently track 1 Healthcare story that mention U.S. Department of Health and Human Services (CMS), all published on July 27, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 23 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering U.S. Department of Health and Human Services (CMS). Shared-story counts are live from our verified record — not editorial picks.
Copay accumulator programs are shifting thousands in drug costs back to patients, causing financial distress and potential treatment delays. Larry Gruber’s experience with Oscar Health highlights the human toll of insurance practices that prioritize cost over care.
U.S. Department of Health and Human Services (CMS) is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
